IP Library Granted Patent US 12,246,169
Granted Patent B2
US 12,246,169 · App. 16/975,433 · Granted Mar 11, 2025

Medical delivery devices having low lubricant hydrophobic syringe barrels

Inventors: Eric J. Van Voorhees (Landenberg, PA); Benjamin Wright (Elkton, MD)
Assignee: W.L. Gore & Associates, Inc.
A61M5/31513A61M5/20A61M5/3129A61M2005/3131A61M2205/0216A61M2205/0222A61M2205/0238
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,246,169
App. No.
16/975,433
Granted
Mar 11, 2025
Kind
B2
Abstract

The present disclosure relates to medical delivery devices that include a barrel having an inner surface that is hydrophobic. The medical delivery device includes a barrel with a hydrophobic inner surface and a stopper that can provide air and liquid impermeability while also possessing on or more of: a low break loose force, a low average glide force, and a low glide force variation. The contact angle of the inner surface of the barrel is greater than 90°.

Claims (25)

1. A medical delivery device comprising:

a barrel having an inner surface; and

a stopper contacting at least a portion of the inner surface of the barrel; said stopper having a compressibility between about 4.5% to about 7.9% measured against said barrel,

wherein said inner surface of barrel has a water contact angle greater than 90°,

wherein the stopper has a sliding surface less than about 2 mm, and

wherein the stopper has a glide force variation less than about 1.3 N when calculated according to the Glide Force Variation test method.

2. The medical delivery device of claim 1 , wherein said inner surface of the barrel has a water contact angle between 96° and about 120°.

3. The medical delivery device of claim 1 , wherein said inner surface is free or substantially free of lubricants.

4. The medical delivery device of claim 1 , wherein said stopper is covered with one or more fluoropolymer layers.

5. The medical delivery device of claim 4 , wherein the one or more fluoropolymer layers comprise a composite material having a barrier layer and a porous layer, the barrier layer comprising at least one member selected from the group consisting of densified expanded polytetrafluoroethylene, expanded polytetrafluoroethylene, polytetrafluoroethylene, fluorinated ethylene propylene, polyethylene, polypropylene, polyvinylidene fluoride, polyvinylfluoride, perfluoropropylevinylether, Parylene AF-4, Parylene VT-4, Parylene C, Parylene N, a perfluoroalkoxy polymer, and copolymers and combinations thereof.

6. The medical delivery device of claim 4 , wherein said one or more fluoropolymer layers comprise densified expanded polytetrafluoroethylene or expanded polytetrafluoroethylene.

7. The medical delivery device of claim 1 , wherein stopper has a break loose force less than about 7 N.

8. The medical delivery device of claim 1 , wherein the stopper has an average glide force less than about 4 N.

9. A medical delivery device comprising:

a barrel having an inner surface; and

a stopper contacting at least a portion of the inner surface of the barrel; said stopper having a compressibility between about 4.5% to 7.9% measured against said barrel,

wherein said inner surface of barrel has a water contact angle greater than 90°.

wherein the stopper has a sliding surface less than about 2 mm, and wherein the stopper has an average glide force less than about 4 N.

10. The medical delivery device of claim 9 , wherein said inner surface of the barrel has a water contact angle between 96° and about 120°.

11. The medical delivery device of claim 9 , wherein said inner surface is free or substantially free of lubricants.

12. The medical delivery device of claim 9 , wherein said stopper is covered with one or more fluoropolymer layers.

13. The medical delivery device of claim 12 , wherein the one or more fluoropolymer layers comprise a composite material having a barrier layer and a porous layer, the barrier layer comprising at least one member selected from the group consisting of densified expanded polytetrafluoroethylene, expanded polytetrafluoroethylene, polytetrafluoroethylene, fluorinated ethylene propylene, polyethylene, polypropylene, polyvinylidene fluoride, polyvinylfluoride, perfluoropropylevinylether, Parylene AF-4, Parylene VT-4, Parylene C, Parylene N, a perfluoroalkoxy polymer, and copolymers and combinations thereof.

14. The medical delivery device of claim 12 , wherein said one or more fluoropolymer layers comprise densified expanded polytetrafluoroethylene or expanded polytetrafluoroethylene.

15. The medical delivery device of claim 9 , wherein stopper has a break loose force less than about 7 N.

16. The medical delivery device of claim 9 , wherein the stopper includes two or more sealing ribs.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2025
From: VAN VOORHEES, ERIC J.; WRIGHT, BENJAMIN
To: W. L. GORE & ASSOCIATES, INC.
Reel/Frame 070415/0126 →
Continuity (2)
Provisional Application 62639317 · Mar 6, 2018
Related Publication 20210030970A1 · Feb 4, 2021
References Cited (56)
US 4303070A · Ichikawa · 1981 [cited by examiner]
US 5374473A · Knox et al. · 1994 [cited by applicant]
US 5586975A · Tanaka · 1996 [cited by examiner]
US 5708044A · Branca · 1998 [cited by applicant]
US 5792525A · Fuhr et al. · 1998 [cited by applicant]
US 6030694A · Dolan et al. · 2000 [cited by applicant]
US 6090081A · Sudo · 2000 [cited by examiner]
US 6541589B1 · Baillie · 2003 [cited by applicant]
US 7521010B2 · Kennedy · 2009 [cited by applicant]
US 7531611B2 · Sabol et al. · 2009 [cited by applicant]
US 8637144B2 · Ford · 2014 [cited by applicant]
US 8658707B2 · Xu et al. · 2014 [cited by applicant]
US 8722178B2 · Ashmead · 2014 [cited by examiner]
US 9139669B2 · Xu et al. · 2015 [cited by applicant]
US 9441088B2 · Sbriglia et al. · 2016 [cited by applicant]
US 9597458B2 · Ashmead et al. · 2017 [cited by applicant]
US 9732184B2 · Sbriglia et al. · 2017 [cited by applicant]
US 9926416B2 · Sbriglia · 2018 [cited by applicant]
US 10471211B2 · Rusch · 2019 [cited by examiner]
US 20030023206A1 · Bausmith, III · 2003 [cited by examiner]
US 20100298738A1 · Felts · 2010 [cited by examiner]
US 20110137263A1 · Ashmead · 2011 [cited by examiner]
US 20110313363A1 · D'Souza · 2011 [cited by examiner]
US 20120123345A1 · Felts · 2012 [cited by examiner]
US 20120251748A1 · Ashmead · 2012 [cited by examiner]
US 20120252709A1 · Felts · 2012 [cited by examiner]
US 20130197451A1 · Ishii · 2013 [cited by examiner]
US 20130200549A1 · Felts · 2013 [cited by examiner]
US 20140212612A1 · Sbriglia · 2014 [cited by applicant]
US 20140303567A1 · Qurishi · 2014 [cited by examiner]
US 20150021339A1 · Felts · 2015 [cited by examiner]
US 20150098084A1 · Felts · 2015 [cited by examiner]
US 20150126941A1 · Felts · 2015 [cited by examiner]
US 20150148751A1 · Yotsutsuji · 2015 [cited by examiner]
US 20150297800A1 · Weikart · 2015 [cited by examiner]
US 20160022918A1 · Gunzel · 2016 [cited by examiner]
US 20160032044A1 · Sbriglia et al. · 2016 [cited by applicant]
US 20160032069A1 · Sbriglia · 2016 [cited by applicant]
US 20160032071A1 · Sbriglia et al. · 2016 [cited by applicant]
US 20170203043A1 · Rusch · 2017 [cited by examiner]
US 20170296752A1 · Masuyama · 2017 [cited by examiner]
US 20170296756A1 · Giraud · 2017 [cited by examiner]
US 20190000919A1 · Brockmeyer · 2019 [cited by examiner]
US 20190352778A1 · Felts · 2019 [cited by examiner]
EP 0026940 · 1984 [cited by applicant]
JP 201789528 · 2017 [cited by applicant]
WO WO9413469 · 1994 [cited by applicant]
WO WO2012006555A1 · 2012 [cited by examiner]
WO WO2013064590A1 · 2013 [cited by examiner]
WO WO2015054282 · 2014 [cited by applicant]
WO WO2015054282A2 · 2015 [cited by examiner]
WO WO2017087798A1 · 2017 [cited by examiner]
WO WO2017123840 · 2017 [cited by applicant]
“What is contact angle?” www.brighton-science.com/what-is-contact-angle (accessed Aug. 1, 2024) (Year: 2024). [cited by examiner]
International Standard ISO 11040-4, Prefilled syringes Part 4: Glass barrels for injectables and sterilized subassembled syringes ready for filling. [cited by applicant]
Ville Jokinen et al; Biomicrofluidics, Oxygen and nitrogen plasma hydrophilization and hydrophobic recovery of polymers, vol. 6, Issue 1 (2012). [cited by applicant]